Statistical Services, Dynamic patient randomisation, adaptive trial design, dynamic randomisation, randomisation lists, minimisation designs, specialised biostatistical services, complex randomisation, psychometric services for ePRO

Biostatistical Services

Almac offers world-class biostatisticalsServices related to patient randomisation methodologies, IXRS implementation considerations and electronic patient reported outcomes (ePRO). The strength of this offering revolves around the quality of Almac’s biostatisticians and their expertise, experience, and reputations in the clinical R&D community.

Almac’s biostatisticians provide guidance relating to crucial aspects of trial planning such as study design, randomisation strategy, blinding and regulatory considerations. Further, Almac is a renowned industry leader in providing expert advice in complex study designs (e.g., adaptive trial design implementation, covariate adaptive dynamic randomisation methodologies and cohort designs).

From simple to complex studies, Almac’s knowledgeable and customer-focused biostatistical consultants will ensure that your needs are fully understood and accurately implemented so that study objectives are fully met.

IXRS Randomisation Methodologies
Dedicated IXRS Biostatistical Consulting
Randomisation List Generation Services
ePRO/ Psychometric Support

Almac Advantage

Customer Service

Almac’s customer service is consistently rated one of the highest in the industry by sites and sponsors. Our project teams go above and beyond to ensure that all users’ needs are met throughout the life of a trial.

Global Reach

Almac’s technology and services have been deployed globally since 1995 in over 85 countries and 60 languages.

User-Friendly Technology

Satisfied users are productive users. Almac is always looking for new ways to improve the user-friendliness of our technology.


Almac has conducted over 1900 clinical trials worldwide, involving 1.8 million patients at 130,000 sites in over 85 countries and 60 languages. Our clinical technologies’ client base includes approximately 250 firms, with several Top 50 biopharmaceutical firms and over 150 small and medium-sized companies.

Flash replacement image